A clinical analysis of the effectiveness of combined treatment of retinal macular edema

Purpose: to assess the effectiveness of combined treatment of macular edema (ME) of varied etiology. Materials and methods. The results of combined treatment of 32 patients (38 eyes) aged 55 to 75. Of these, 13 patients (15 eyes) had postocclusion MO, 12 patients (14 eyes) had diabetic MO and 7 patients (9 eyes) had an exudate form of age-related maculardegeneration. Two groups of patients were formed depending on the treatment administered. Group 1 (14 patients) intravitreally received an inhibitor of neoangiogenesis, Ranibizumab, whilst group 2 (18 patients) received combined treatment which included a prolonged corticosteroid (Diprospan) administered into sub-Tenon’s space, laser coagulation and intravitreal administration of Ranibizumab. All patients underwent high-definition optical coherent tomography examinations (HDOCT, OCT 4.000 Cirrus Humphrey - Zeiss, San Leandro, USA) and computer tonometry, performed on a visual field analyzer Peritest 30/50/100 using the Macula software. Results. The combined treatment of patients with ME resulted in a stable improvement of visual acuity (averagely by 0.55 in 88 % of cases), rapid retinal edema reduction (its thinning) in 74 % of cases, reduction of risk of neovascular complications, and stabilization of the results achieved. Conclusion. Due to a number of components involved and pathogenetic emphasis, the combined treatment promotes the effectiveness of functional rehabilitation of patients with ME of varied origin // Russian Ophthalmological Journal, 2017; 1: 5-8. doi: 10.21516/2072-0076-2017-10-1-5-8

макулярный отек, кортикостероиды, ингибиторы неоангиогенеза, лазерная коагуляция сетчатки, macular edema, corticosteroids, inhibitors of neoangiogenesis, laser photocoagulation of the retina

1. Алпатов С.А., Щуко А.Г., Урнева Е.М., Малышев В.В. Возрастная макулярная дегенерация. Москва: ГОЭТАР-Медиа; 2009.

2. Нероев В.В. Современные аспекты лечения диабетического макулярного отека. Российский офтальмологический журнал. 2012; 5(1): 4-7.

3. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch. Ophthalmol. 1985; 103: 1796-806.

4. Rehak J., Rehak M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr. Eye Res. 2008; 33(2): 111-31.

5. Алтынбаев У.Р., Бикбов М.М., Маликова А.Л. Способ лечения макулярного отека различного генеза. Патент РФ № 2393824. 2010.

6. Биландарли Л.Ш. Алиева Н.И., Абдуллаева Э.А. Лечение макулярного отека при окклюзии ретинальных вен интравитреальным введением бевацизумаба. Российский офтальмологический журнал. 2010; 3(2): 4-6.

7. Bloom S.M., Brucker A.J. Laser surgery of the posterior segment. 2nd edn. Philadelphia/New York: Lippincott-Raven Publ. 1994.

8. Cohen S.Y. Anti-VEGF drugs as the 2009 first-line therapy for choroidal neovascularization in pathologic myopia. Retina. 2009; 29: 1062-6.

9. Chun D.W., Heier J.S., Topping T.M., et al. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology. 2006; 113: 1706-12.

10. Cohen S.Y., Laroche A., Leguen Y., Soubrane G.J. Etiology of choroidal neovascularization in young patients. Ophthalmology. 1996; 103: 1241-4.

11. Das A., Friberg T.R. Therapy for Ocular Angiogenesis. Principles and Practice. Philadelphia, PA: Lippincott Williams & Wilkins; 2010.

12. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV: Diabetic macular edema. Ophthalmology. 1984; 91: 1464-74.